Interference of deferasirox with assays for serum iron and serum unsaturated iron binding capacity during iron chelating therapy

Clinica Chimica Acta

Volumn 412, Issue 23-24, 2011, Pages 2261-2266

  Ikuta, Katsuya ^a   Ito, Satoshi ^a   Tanaka, Hiroki ^a   Sasaki, Katsunori ^a   Torimoto, Yoshihiro ^a   Fujiya, Mikihiro ^a   Kohgo, Yutaka ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

Deferasirox; Iron chelation; Serum iron; Unsaturated iron binding capacity (UIBC)

Indexed keywords

BIOLOGICAL MARKER; DEFERASIROX; FERRIC AMMONIUM CITRATE; IRON; TRANSFERRIN;

ARTICLE; BIOASSAY; COMPLEX FORMATION; CONTROLLED STUDY; HUMAN; IRON BINDING CAPACITY; IRON BLOOD LEVEL; IRON CHELATION; IRON METABOLISM; OUTCOME ASSESSMENT; PHOTOMETRY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

BENZOIC ACIDS; HUMANS; IRON; IRON CHELATING AGENTS; TRIAZOLES;

EID: 80053627985     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2011.08.020     Document Type: Article

References (20)

1. Galanello R., Piga A., Forni G.L., et al. Phase II clinical evaluation of deferasirox, a once-daily oral chelating agent, in pediatric patients with beta-thalassemia major. Haematologica 2006, 91:1343-1351.
2. Cappellini M.D., Cohen A., Piga A., et al. A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with β-thalassemia. Blood 2006, 107:3455-3462.
3. Vichinsky E., Onyekwere O., Porter J., et al. A randomised comparison of deferasirox versus deferoxamine for the treatment of transfusional iron overload in sickle cell disease. Br J Haematol 2007, 136:501-508.
4. Piga A., Galanello R., Forni G.L., et al. Randomized phase II trial of deferasirox (Exjade, ICL670), a once-daily, orally-administered iron chelator, in comparison to deferoxamine in thalassemia patients with transfusional iron overload. Haematologica 2006, 91:873-880.
5. Neufeld E.J. Oral chelators deferasirox and deferiprone for transfusional iron overload in thalassemia major: new data, new questions. Blood 2006, 107:3436-3441.
6. Shashaty G., Frankewich R., Chakraborti T., et al. Deferasirox for the treatment of chronic iron overload in transfusional hemosiderosis. Oncology (Williston Park) 2006, 20:1799-1806.
7. Ohno N., Sakai T. Spectrophotometric determination of iron in boiler and well waters by flow injection analysis using 2-nitroso-5-(N-propyl-N-sulphopropylamino)phenol. Analyst 1987, 112:1127-1130.
8. Stookey L.L. Ferrozine - a new spectrophotometric reagent for iron. Anal Chem 1970, 42:779-781.
9. Bouda J. Simple determination of iron-binding capacity with bathophenanthroline. Clin Chim Acta 1969, 23:511-512.
10. Bouda J. Determination of iron with bathophenanthroline without deproteinisation. Clin Chim Acta 1968, 21:159-160.
11. Smith F.E., Herberd J., Gaudin J., Hennessy D.J., Reid G.R. Serum iron determination using ferene triazine. Clin Biochem 1984, 17:306-310.
12. Hennessy D.J., Reid G.R., Smith F.E., Thompson S.L. Ferene - a new spectrophotometric reagent for iron. Can J Chem 1984, 62:721-724.
13. Chirnomas D., Smith A.L., Braunstein J., et al. Deferasirox pharmacokinetics in patients with adequate versus inadequate response. Blood 2009, 114:4009-4013.
14. Singh S., Hider R.C., Porter J.B. A direct method for quantification of non-transferrin-bound iron. Anal Biochem 1990, 186:320-323.
15. Gosriwatana I., Loreal O., Lu S., Brissot P., Porter J., Hider R.C. Quantification of non-transferrin-bound iron in the presence of unsaturated transferrin. Anal Biochem 1999, 273:212-220.
16. Lebitasy M., Ampe E., Hecq J.D., Karmani L., Nick H., Galanti L. Ability of deferasirox to bind iron during measurement of iron. Clin Chem Lab Med 2010, 48:427-429.
17. Tenenbein M., Yatscoff R.W. The total iron-binding capacity in iron poisoning. Is it useful?. Am J Dis Child 1991, 145:437-439.
18. Roberts W.L., Smith P.T., Martin W.J., Rainey P.M. Performance characteristics of three serum iron and total iron-binding capacity methods in acute iron overdose. Am J Clin Pathol 1999, 112:657-664.
19. Kreutzer H.J. An immunological turbidimetric method for serum transferrin determination. J Clin Chem Clin Biochem 1976, 14:401-406.
20. Saito H. New method for determining total iron-binding capacity of serum (TIBC) with radioiron by eliminating iron from transferring. J Nucl Med 1971, 12:489-492.